Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Anti-Retroviral Agents"" wg kryterium: Temat


Tytuł :
Disparity in HIV Service Interruption in the Outbreak of COVID-19 in South Carolina.
Autorzy :
Qiao S; The South Carolina SmartState Center of Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA. .; Department of Health Promotion Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA. .
Li Z; The South Carolina SmartState Center of Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.; Department of Geography, University of South Carolina, Columbia, SC, USA.
Weissman S; The South Carolina SmartState Center of Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.; Department of Internal Medicine, School of Medicine, University of South Carolina, Columbia, SC, USA.
Li X; The South Carolina SmartState Center of Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.; Department of Health Promotion Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
Olatosi B; The South Carolina SmartState Center of Healthcare Quality, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.; Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA.
Davis C; South Carolina Department of Health and Environment Control, Columbia, SC, USA.
Mansaray AB; South Carolina Department of Health and Environment Control, Columbia, SC, USA.
Pokaż więcej
Źródło :
AIDS and behavior [AIDS Behav] 2021 Jan; Vol. 25 (1), pp. 49-57.
Typ publikacji :
Journal Article
MeSH Terms :
Healthcare Disparities*
SARS-CoV-2*
Anti-Retroviral Agents/*therapeutic use
COVID-19/*psychology
Continuity of Patient Care/*organization & administration
Disease Outbreaks/*prevention & control
HIV Infections/*drug therapy
Health Services Accessibility/*statistics & numerical data
Ambulatory Care Facilities ; Anti-Retroviral Agents/administration & dosage ; COVID-19/epidemiology ; COVID-19/prevention & control ; Delivery of Health Care ; HIV Infections/epidemiology ; HIV Infections/psychology ; Health Status Disparities ; Humans ; Pandemics ; Qualitative Research ; South Carolina/epidemiology
Czasopismo naukowe
Tytuł :
Alcohol Use and Antiretroviral Adherence Among Patients Living with HIV: Is Change in Alcohol Use Associated with Change in Adherence?
Autorzy :
Williams EC; Health Services Research & Development (HSR&D), Center of Innovation for Veteran-Centered Value-Driven Care, Veteran Affairs (VA) Puget Sound Health Care System, 1660 S. Columbian Way, S-152, Seattle, WA, 98108, USA. .; Department of Health Services, University of Washington, Seattle, WA, USA. .
McGinnis KA; Veterans Aging Cohort Study Coordinating Center, VA Connecticut Healthcare System, West Haven, CT, USA.
Rubinsky AD; Health Services Research & Development (HSR&D), Center of Innovation for Veteran-Centered Value-Driven Care, Veteran Affairs (VA) Puget Sound Health Care System, 1660 S. Columbian Way, S-152, Seattle, WA, 98108, USA.; Kidney Health Research Collaborative, University of California, San Francisco and VA San Francisco Health Care System, San Francisco, CA, USA.
Matson TE; Health Services Research & Development (HSR&D), Center of Innovation for Veteran-Centered Value-Driven Care, Veteran Affairs (VA) Puget Sound Health Care System, 1660 S. Columbian Way, S-152, Seattle, WA, 98108, USA.; Department of Health Services, University of Washington, Seattle, WA, USA.; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Bobb JF; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Lapham GT; Health Services Research & Development (HSR&D), Center of Innovation for Veteran-Centered Value-Driven Care, Veteran Affairs (VA) Puget Sound Health Care System, 1660 S. Columbian Way, S-152, Seattle, WA, 98108, USA.; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Edelman EJ; Schools of Medicine and Public Health, Yale University, New Haven, CT, USA.
Satre DD; Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco, CA, USA.; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Catz SL; Betty Irene Moore School of Nursing, University of California at Davis, Sacramento, CA, USA.
Richards JE; Department of Health Services, University of Washington, Seattle, WA, USA.; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Bryant KJ; National Institute On Alcohol Abuse and Alcoholism, Bethesda, MD, USA.
Marshall BDL; Department of Epidemiology, Brown University School of Public Health, Providence, RI, USA.
Kraemer KL; Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, PA, USA.
Crystal S; Health Services Research, Rutgers University, New Brunswick, NJ, USA.
Gordon AJ; Division of Epidemiology, Department of Internal Medicine, Program for Addiction Research, Clinical Care, Knowledge and Advocacy (PARCKA), University of Utah School of Medicine, Salt Lake City, UT, USA.; Informatics, Decision-Enhancement, and Analytic Sciences Center, VA Salt Lake City Health Care System, Salt Lake City, UT, USA.
Skanderson M; Veterans Aging Cohort Study Coordinating Center, VA Connecticut Healthcare System, West Haven, CT, USA.
Fiellin DA; Veterans Aging Cohort Study Coordinating Center, VA Connecticut Healthcare System, West Haven, CT, USA.; Schools of Medicine and Public Health, Yale University, New Haven, CT, USA.
Justice AC; Veterans Aging Cohort Study Coordinating Center, VA Connecticut Healthcare System, West Haven, CT, USA.; Schools of Medicine and Public Health, Yale University, New Haven, CT, USA.
Bradley KA; Health Services Research & Development (HSR&D), Center of Innovation for Veteran-Centered Value-Driven Care, Veteran Affairs (VA) Puget Sound Health Care System, 1660 S. Columbian Way, S-152, Seattle, WA, 98108, USA.; Department of Health Services, University of Washington, Seattle, WA, USA.; Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.; Center of Excellence in Substance Abuse Treatment and Education (CESATE) VA Puget Sound Healthcare System-Seattle Division, Seattle, WA, USA.; Department of Medicine, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło :
AIDS and behavior [AIDS Behav] 2021 Jan; Vol. 25 (1), pp. 203-214.
Typ publikacji :
Journal Article
MeSH Terms :
Alcohol Drinking*/epidemiology
Anti-Retroviral Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Medication Adherence*
Aged ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
The association between severe menopausal symptoms and engagement with HIV care and treatment in women living with HIV.
Autorzy :
Solomon D; Institute for Global Health, University College London, UK.
Sabin CA; Institute for Global Health, University College London, UK.
Burns F; Institute for Global Health, University College London, UK.; Royal Free London NHS Foundation Trust, UK.
Gilson R; Institute for Global Health, University College London, UK.
Allan S; Coventry and Warwickshire Partnership NHS Trust, UK.
de Ruiter A; Guy's & St Thomas' NHS Foundation Trust, UK.; ViiV Healthcare, UK.
Dhairyawan R; Barking, Havering and Redbridge NHS Trust, UK.
Fox J; Guy's & St Thomas' NHS Foundation Trust, UK.
Gilleece Y; Brighton & Sussex University Hospitals NHS Trust, UK.; Brighton & Sussex Medical School, UK.
Jones R; Chelsea and Westminster Hospital NHS Foundation Trust, UK.
Post F; King's College Hospital NHS Foundation Trust, UK.
Reeves I; Homerton University Hospital NHS Foundation Trust, UK.
Ross J; University Hospital Birmingham NHS Foundation Trust, UK.
Ustianowski A; North Manchester General Hospital, Penine Acute Hospitals NHS Trust, UK.
Shepherd J; UK Community Advisory Board.
Tariq S; Institute for Global Health, University College London, UK.
Pokaż więcej
Źródło :
AIDS care [AIDS Care] 2021 Jan; Vol. 33 (1), pp. 101-108. Date of Electronic Publication: 2020 Apr 11.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Retroviral Agents/*administration & dosage
Antiretroviral Therapy, Highly Active/*methods
HIV Infections/*drug therapy
Medication Adherence/*statistics & numerical data
Menopause/*physiology
Menopause/*psychology
Anti-Retroviral Agents/therapeutic use ; England/epidemiology ; Female ; HIV Infections/complications ; HIV Infections/epidemiology ; Hot Flashes/complications ; Humans ; Middle Aged
Czasopismo naukowe
Tytuł :
Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.
Autorzy :
Sriram K; Department of Pharmacology, University of California San Diego, La Jolla, CA 92093.
Loomba R; Department of Medicine, University of California San Diego, La Jolla, CA 92093.
Insel PA; Department of Pharmacology, University of California San Diego, La Jolla, CA 92093; .; Department of Medicine, University of California San Diego, La Jolla, CA 92093.
Pokaż więcej
Źródło :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2020 Nov 24; Vol. 117 (47), pp. 29274-29282. Date of Electronic Publication: 2020 Nov 17.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Angiotensin-Converting Enzyme Inhibitors/*therapeutic use
Anti-Retroviral Agents/*therapeutic use
COVID-19/*drug therapy
Renin-Angiotensin System/*drug effects
Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/pharmacology ; Animals ; Anti-Retroviral Agents/adverse effects ; Anti-Retroviral Agents/pharmacology ; Clinical Trials as Topic ; Humans
Czasopismo naukowe
Tytuł :
Antiretroviral treatment interruption among people living with HIV during COVID-19 outbreak in China: a nationwide cross-sectional study.
Autorzy :
Sun Y; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Li H; Shizhong District Center for Disease Control and Prevention, Jinan, China.
Luo G; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Meng X; Wuxi Municipal Center for Disease Control and Prevention, Wuxi, China.
Guo W; UNAIDS China Office, Beijing, China.
Fitzpatrick T; Department of Internal Medicine, University of Washington, Seattle, WA, USA.
Ao Y; Department of Infectious Diseases, Guangzhou Eighth People's Hospital affiliated to Guangzhou Medical School, Guangzhou, China.
Feng A; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Liang B; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Zhan Y; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
Sande A; UNAIDS China Office, Beijing, China.
Xie F; Chongqing Blue Sky nongovernment organization, Chongqing, China.
Wang Y; School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Qian HZ; SJTU-Yale Joint Center for Biostatistics and Data Science, Department of Bioinformatics and Biostatistics, School of Life Science and Biotechnology, Shanghai Jiao Tong University (SJTU), Shanghai, China.; Yale School of Public Health, New Haven, CT, USA.
Cai Y; School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Zou H; School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.; School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Shenzhen Center for Disease Control and Prevention, Shenzhen, China.; Kirby Institute, University of New South Wales, Sydney, Australia.
Pokaż więcej
Źródło :
Journal of the International AIDS Society [J Int AIDS Soc] 2020 Nov; Vol. 23 (11), pp. e25637.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Continuity of Patient Care*
SARS-CoV-2*
Anti-Retroviral Agents/*supply & distribution
Anti-Retroviral Agents/*therapeutic use
COVID-19/*epidemiology
HIV Infections/*drug therapy
Adult ; Anti-Retroviral Agents/administration & dosage ; China/epidemiology ; Cross-Sectional Studies ; Female ; Health Care Surveys ; Humans ; Logistic Models ; Male ; Middle Aged ; Risk Factors ; Rural Population ; Surveys and Questionnaires ; Travel
Czasopismo naukowe
Tytuł :
Effect of nevirapine, efavirenz and lopinavir/ritonavir on the therapeutic concentration and toxicity of lumefantrine in people living with HIV at Lagos University Teaching Hospital, Nigeria.
Autorzy :
Usman SO; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria. Electronic address: .
Oreagba IA; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria; West African Postgraduate College of Pharmacists, Yaba, Lagos State, Nigeria; National Agency for Food and Drug Administration and Control, Wuse, Abuja, Nigeria.
Akinyede AA; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.
Agbaje EO; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.
Akinleye MO; Department of Pharmaceutical Chemistry, Faculty of Pharmacy of the University of Lagos, Nigeria.
Onwujuobi AG; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.
Ken-Owotor C; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.
Adeuja O; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.
Ogunfowokan T; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.
Kogbe S; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.
Owolabi ET; Apin Clinic, Lagos University Teaching Hospital, Idi-Araba, Lagos State, Nigeria.
Adeniji H; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.
Busari AW; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.
Hassan OO; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.
Abideen G; Department of Pharmacology, Therapeutics and Toxicology, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria.
Akanmu AS; Department of Haematology and Blood Transfusion, Faculty of Clinical Science, College of Medicine of the University of Lagos, Idi-Araba, Lagos State, Nigeria; Apin Clinic, Lagos University Teaching Hospital, Idi-Araba, Lagos State, Nigeria.
Pokaż więcej
Źródło :
Journal of pharmacological sciences [J Pharmacol Sci] 2020 Nov; Vol. 144 (3), pp. 95-101. Date of Electronic Publication: 2020 Aug 05.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Interactions*
Anti-Retroviral Agents/*adverse effects
Antimalarials/*adverse effects
Artemether, Lumefantrine Drug Combination/*adverse effects
Benzoxazines/*adverse effects
HIV Infections/*drug therapy
Malaria/*drug therapy
Nevirapine/*adverse effects
Adult ; Alkynes ; Anti-Retroviral Agents/administration & dosage ; Anti-Retroviral Agents/blood ; Antimalarials/administration & dosage ; Antimalarials/blood ; Artemether, Lumefantrine Drug Combination/administration & dosage ; Artemether, Lumefantrine Drug Combination/blood ; Benzoxazines/administration & dosage ; Benzoxazines/blood ; Cyclopropanes ; Drug Combinations ; Drug Therapy, Combination ; Female ; HIV Infections/complications ; Humans ; Lopinavir ; Malaria/complications ; Male ; Middle Aged ; Nevirapine/administration & dosage ; Nevirapine/blood ; Nigeria ; Ritonavir ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Models of SIV rebound after treatment interruption that involve multiple reactivation events.
Autorzy :
van Dorp CH; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
Conway JM; Department of Mathematics and Center for Infectious Disease Dynamics, Pennsylvania State University, University Park, Pennsylvania, United States of America.
Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America.
Whitney JB; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, United States of America.
Perelson AS; Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
Pokaż więcej
Źródło :
PLoS computational biology [PLoS Comput Biol] 2020 Oct 01; Vol. 16 (10), pp. e1008241. Date of Electronic Publication: 2020 Oct 01 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Anti-Retroviral Agents*/administration & dosage
Anti-Retroviral Agents*/pharmacology
Anti-Retroviral Agents*/therapeutic use
Simian Acquired Immunodeficiency Syndrome*/drug therapy
Simian Acquired Immunodeficiency Syndrome*/virology
Simian Immunodeficiency Virus*/drug effects
Simian Immunodeficiency Virus*/pathogenicity
Simian Immunodeficiency Virus*/physiology
Virus Activation*/drug effects
Virus Activation*/physiology
Animals ; Biomarkers ; Computational Biology ; Computer Simulation ; Macaca mulatta ; Viral Load/drug effects
Czasopismo naukowe
Tytuł :
Quality of life in individuals initiating antiretroviral therapy: a cohort study.
Autorzy :
Pimentel GS; Universidade Federal de Minas Gerais. Faculdade de Farmácia. Programa de Pós-Graduação em Medicamentos e Assistência Farmacêutica. Belo Horizonte, MG, Brasil.
Ceccato MDGB; Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Belo Horizonte, MG, Brasil.
Costa JO; University of New South Wales. Centre for Big Data Research in Health. Faculty of Medicine. Sydney, Australia.; Universidade Federal de Minas Gerais. Faculdade de Medicina. Pós-Graduação em Saúde Pública. Belo Horizonte, MG, Brasil.
Mendes JC; Universidade Federal de Minas Gerais. Faculdade de Farmácia. Programa de Pós-Graduação em Medicamentos e Assistência Farmacêutica. Belo Horizonte, MG, Brasil.
Bonolo PF; Universidade Federal de Minas Gerais. Faculdade de Medicina. Departamento de Medicina Preventiva e Social. Belo Horizonte, MG, Brasil.
Silveira MR; Universidade Federal de Minas Gerais. Faculdade de Farmácia. Departamento de Farmácia Social. Belo Horizonte, MG, Brasil.
Pokaż więcej
Źródło :
Revista de saude publica [Rev Saude Publica] 2020 Dec 16; Vol. 54, pp. 146. Date of Electronic Publication: 2020 Dec 16 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Retroviral Agents*/therapeutic use
HIV Infections*/drug therapy
Quality of Life*
Adolescent ; Adult ; Brazil ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Hazardous alcohol use, antiretroviral therapy receipt, and viral suppression in people living with HIV who inject drugs in the United States, India, Russia, and Vietnam.
Autorzy :
Wagman JA; Department of Community Health Sciences, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California, USA.
Wynn A
Matsuzaki M
Gnatienko N
Metsch LR
Del Rio C
Feaster DJ
Nance RM
Whitney BM
Delaney JAC
Kahana SY
Crane HM
Chandler RK
Elliott JC
Altice F
Lucas GM
Mehta SH
Hirsch-Moverman Y
El-Sadr WM
Vu Q
Nguyen Thanh B
Springer SA
Tsui JI
Samet JH
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2020 Dec 01; Vol. 34 (15), pp. 2285-2294.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Alcohol-Related Disorders*/epidemiology
Alcohol-Related Disorders*/virology
Anti-Retroviral Agents*/administration & dosage
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/virology
Substance Abuse, Intravenous*/epidemiology
Substance Abuse, Intravenous*/virology
Adult ; Cross-Sectional Studies ; Female ; Humans ; India/epidemiology ; Male ; Middle Aged ; Russia/epidemiology ; United States ; Vietnam/epidemiology ; Viral Load
Czasopismo naukowe
Tytuł :
Platelet activation in adult HIV-infected patients on antiretroviral therapy: a systematic review and meta-analysis.
Autorzy :
Nkambule BB; School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban, 4000, South Africa. .
Mxinwa V; School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban, 4000, South Africa.
Mkandla Z; School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban, 4000, South Africa.
Mutize T; School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban, 4000, South Africa.
Mokgalaboni K; School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban, 4000, South Africa.
Nyambuya TM; School of Laboratory Medicine and Medical Sciences (SLMMS), College of Health Sciences, University of KwaZulu-Natal, Private Bag X54001, Durban, 4000, South Africa.
Dludla PV; Biomedical Research and Innovation Platform (BRIP), Medical Research Council (MRC), Tygerberg, Cape Town, South Africa.
Pokaż więcej
Źródło :
BMC medicine [BMC Med] 2020 Nov 18; Vol. 18 (1), pp. 357. Date of Electronic Publication: 2020 Nov 18.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Anti-Retroviral Agents/*therapeutic use
HIV Infections/*blood
HIV Infections/*drug therapy
Platelet Activation/*physiology
Anti-Retroviral Agents/pharmacology ; Cardiovascular Diseases/blood ; Cardiovascular Diseases/virology ; Humans ; Platelet Activation/drug effects
Czasopismo naukowe
Tytuł :
Covid-19 treatment-induced neuropsychiatric adverse effects.
Autorzy :
García CAC; Department of Psychiatry, University Hospital Ramón y Cajal, Madrid, Spain. Electronic address: .
Sánchez EBA; Department of Psychiatry, University Hospital Ramón y Cajal, Madrid, Spain.
Huerta DH; Department of Psychiatry, University Hospital Ramón y Cajal, Madrid, Spain.
Gómez-Arnau J; Department of Psychiatry, University Hospital Ramón y Cajal, Madrid, Spain.
Pokaż więcej
Źródło :
General hospital psychiatry [Gen Hosp Psychiatry] 2020 Nov - Dec; Vol. 67, pp. 163-164. Date of Electronic Publication: 2020 Jun 10.
Typ publikacji :
Letter
MeSH Terms :
Adrenal Cortex Hormones/*adverse effects
Anti-Retroviral Agents/*adverse effects
Azithromycin/*adverse effects
Behavioral Symptoms/*chemically induced
COVID-19/*drug therapy
Cognitive Dysfunction/*chemically induced
Delirium/*chemically induced
Immunologic Factors/*adverse effects
Neurotoxicity Syndromes/*etiology
Anti-Retroviral Agents/toxicity ; COVID-19/complications ; Humans
SCR Protocol :
COVID-19 drug treatment
Opinia redakcyjna
Tytuł :
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.
Autorzy :
Saag MS; University of Alabama at Birmingham.
Gandhi RT; Harvard Medical School and Massachusetts General Hospital, Boston.
Hoy JF; Monash University and Alfred Hospital, Melbourne, Australia.
Landovitz RJ; University of California, Los Angeles.
Thompson MA; AIDS Research Consortium of Atlanta, Atlanta, Georgia.
Sax PE; Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts.
Smith DM; University of California, San Diego, La Jolla.
Benson CA; University of California, San Diego, La Jolla.
Buchbinder SP; San Francisco Department of Public Health and University of California, San Francisco.
Del Rio C; Emory University School of Medicine, Atlanta, Georgia.
Eron JJ Jr; School of Medicine, University of North Carolina, Chapel Hill.
Fätkenheuer G; University Hospital Cologne, Cologne, Germany.
Günthard HF; University Hospital Zurich and Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
Molina JM; University of Paris and Saint-Louis/Lariboisière Hospitals, APHP, Paris, France.
Jacobsen DM; International Antiviral Society-USA, San Francisco, California.
Volberding PA; University of California, San Francisco.
Pokaż więcej
Źródło :
JAMA [JAMA] 2020 Oct 27; Vol. 324 (16), pp. 1651-1669.
Typ publikacji :
Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Retroviral Agents/*therapeutic use
HIV Infections/*drug therapy
HIV Infections/*prevention & control
AIDS-Related Opportunistic Infections/drug therapy ; Age Factors ; Anti-Retroviral Agents/economics ; Betacoronavirus ; COVID-19 ; Comorbidity ; Coronavirus Infections/epidemiology ; Drug Administration Schedule ; Drug Costs ; Drug Resistance, Viral/genetics ; Drug Substitution/standards ; Drug Therapy, Combination/methods ; Female ; HIV Infections/blood ; HIV Infections/diagnosis ; Humans ; International Agencies ; Male ; Pandemics ; Pneumonia, Viral/epidemiology ; Polypharmacy ; Pre-Exposure Prophylaxis/methods ; Pregnancy ; Pregnancy Complications, Infectious/drug therapy ; RNA, Viral/blood ; SARS-CoV-2 ; Societies, Medical ; United States ; Viral Load/genetics
Czasopismo naukowe
Tytuł :
Higher iron stores and the HFE 187C>G variant delay onset of peripheral neuropathy during combination antiretroviral therapy.
Autorzy :
Kallianpur AR; Genomic Medicine Institute, Cleveland Clinic/Lerner Research Institute, Cleveland, Ohio, United States of America.; Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, United States of America.; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States of America.
Wen W; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Erwin AL; Genomic Medicine Institute, Cleveland Clinic/Lerner Research Institute, Cleveland, Ohio, United States of America.
Clifford DB; Division of Infectious Diseases, Departments of Medicine and Neurology, Washington University School of Medicine, Saint Louis, Missouri, United States of America.
Hulgan T; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Robbins GK; Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Oct 15; Vol. 15 (10), pp. e0239758. Date of Electronic Publication: 2020 Oct 15 (Print Publication: 2020).
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Retroviral Agents/*adverse effects
Antiretroviral Therapy, Highly Active/*adverse effects
Genetic Variation/*genetics
Hemochromatosis Protein/*genetics
Iron/*metabolism
Peripheral Nervous System Diseases/*chemically induced
Peripheral Nervous System Diseases/*genetics
Adult ; Anti-Retroviral Agents/therapeutic use ; Female ; Ferritins/genetics ; Genotype ; HIV Infections/drug therapy ; Hemochromatosis/genetics ; Heterozygote ; Humans ; Male ; Neuralgia/chemically induced ; Neuralgia/genetics ; Receptors, Transferrin/genetics
Czasopismo naukowe
Tytuł :
Favorable outcome of HIV-associated Burkitt lymphoma in the modern combined antiretroviral therapy era.
Autorzy :
Vasseur L; Unit of Hematology-Oncology, Versailles Hospital, Le Chesnay, France.
Prevot S; Université Paris Sud, Faculté de Médecine Paris Sud, Le Kremlin-Bicêtre, France; Pathology Unit, AP-HP, Hopitaux Paris Sud Site Béclère, Clamart, France.
Mounier N; Department of Onco-Hematology, Archet Hospital, Nice, France.
Costagliola D; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.
Besson C; Unit of Hematology-Oncology, Versailles Hospital, Le Chesnay, France; Université Versailles Saint Quentin en Yvelines, Université Paris-Saclay, Communauté Paris-Saclay, Paris, France; INSERM U1018, Centre pour La Recherche en Epidémiologie et Sante des Populations (CESP), Equipe Générations et Santé, Gustave Roussy, Villejuif, France. Electronic address: .
Pokaż więcej
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 Oct; Vol. 138, pp. 189-192. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Letter; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Retroviral Agents/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Burkitt Lymphoma/*drug therapy
HIV Infections/*drug therapy
Lymphoma, AIDS-Related/*drug therapy
Adult ; Anti-Retroviral Agents/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Burkitt Lymphoma/diagnosis ; Burkitt Lymphoma/mortality ; Burkitt Lymphoma/virology ; Drug Therapy, Combination ; Female ; France ; HIV Infections/diagnosis ; HIV Infections/mortality ; HIV Infections/virology ; Humans ; Lymphoma, AIDS-Related/diagnosis ; Lymphoma, AIDS-Related/mortality ; Lymphoma, AIDS-Related/virology ; Male ; Middle Aged ; Progression-Free Survival ; Prospective Studies ; Time Factors
Raport
Tytuł :
Viruses and oral diseases in HIV-infected individuals on long-term antiretroviral therapy: What are the risks and what are the mechanisms?
Autorzy :
Johnson NW; Menzies Health Institute, Griffith University, Gold Coast, Qld, Australia.; Faculty of Dentistry, Oral and Craniofacial Sciences, King's College, London, UK.
Anaya-Saavedra G; Oral Pathology and Medicine Master, Health Care Department, Autonomous Metropolitan University, Mexico City, Mexico.
Webster-Cyriaque J; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Pokaż więcej
Źródło :
Oral diseases [Oral Dis] 2020 Sep; Vol. 26 Suppl 1, pp. 80-90.
Typ publikacji :
Journal Article
MeSH Terms :
Anti-Retroviral Agents*/adverse effects
Anti-Retroviral Agents*/therapeutic use
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Mouth Diseases*/epidemiology
Mouth Diseases*/virology
Neoplasms*/epidemiology
Comorbidity ; Humans ; Papillomaviridae
Czasopismo naukowe
Tytuł :
COVID-19 pandemic and antiretrovirals (ARV) availability in Nigeria: recommendations to prevent shortages.
Autorzy :
Dada DA; Faculty of Pharmaceutical Sciences, Kaduna State University, Kaduna, Nigeria.
Aku E; Department of Microbiology, Kaduna State University, Kaduna, Nigeria.
David KB; Faculty of Pharmaceutical Sciences, Kaduna State University, Kaduna, Nigeria.
Pokaż więcej
Źródło :
The Pan African medical journal [Pan Afr Med J] 2020 Aug 24; Vol. 35 (Suppl 2), pp. 149. Date of Electronic Publication: 2020 Aug 24 (Print Publication: 2020).
Typ publikacji :
Journal Article
MeSH Terms :
Drug Repositioning*
Pandemics*/economics
Anti-Retroviral Agents/*therapeutic use
Coronavirus Infections/*drug therapy
HIV Infections/*drug therapy
Pneumonia, Viral/*drug therapy
Anti-HIV Agents/economics ; Anti-HIV Agents/supply & distribution ; Anti-HIV Agents/therapeutic use ; Anti-Retroviral Agents/economics ; Anti-Retroviral Agents/supply & distribution ; Antiretroviral Therapy, Highly Active/economics ; Betacoronavirus ; COVID-19 ; Coronavirus Infections/economics ; Coronavirus Infections/epidemiology ; Developing Countries ; Drug Costs/trends ; Drug Industry ; HIV Infections/economics ; HIV Infections/epidemiology ; Health Services Accessibility ; Humans ; Insurance, Pharmaceutical Services ; Medication Adherence ; Nigeria/epidemiology ; Pneumonia, Viral/economics ; Pneumonia, Viral/epidemiology ; SARS-CoV-2 ; Viral Load/drug effects
Czasopismo naukowe
Tytuł :
A year-long extended release nanoformulated cabotegravir prodrug.
Autorzy :
Kulkarni TA; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Bade AN; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Sillman B; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Shetty BLD; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Wojtkiewicz MS; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Gautam N; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Hilaire JR; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Sravanam S; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Szlachetka A; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Lamberty BG; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Morsey BM; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Fox HS; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Alnouti Y; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
McMillan JM; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Mosley RL; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA.
Meza J; Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE, USA.
Domanico PL; Department of Global Health Sciences, The Clinton Health Access Initiative, Boston, MA, USA.
Yue TY; Department of Global Health Sciences, The Clinton Health Access Initiative, Boston, MA, USA.
Moore G; Department of Global Health Sciences, The Clinton Health Access Initiative, Boston, MA, USA.
Edagwa BJ; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. .
Gendelman HE; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, USA. .; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, USA. .
Pokaż więcej
Źródło :
Nature materials [Nat Mater] 2020 Aug; Vol. 19 (8), pp. 910-920. Date of Electronic Publication: 2020 Apr 27.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Retroviral Agents/*metabolism
Nanostructures/*chemistry
Prodrugs/*chemistry
Prodrugs/*metabolism
Pyridones/*metabolism
Animals ; Anti-Retroviral Agents/pharmacology ; Anti-Retroviral Agents/toxicity ; Biological Transport ; Delayed-Action Preparations ; Drug Compounding ; Drug Interactions ; Drug Stability ; Mice ; Pyridones/pharmacology ; Pyridones/toxicity
Czasopismo naukowe
Tytuł :
Effects of HIV-1 genotype on baseline CD4+ cell count and mortality before and after antiretroviral therapy.
Autorzy :
Cao Z; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China.
Li J; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, China.
Chen H; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, China.
Song C; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China.
Shen Z; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, China.
Zhou X; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, China.
Lan G; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, China.
Zhu Q; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, China.
Liang S; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Nanning, China.
Xing H; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China.
Liao L; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China.
Feng Y; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China.
Shao Y; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China.
Ruan Y; State Key Laboratory of Infectious Disease Prevention and Control (SKLID), National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing, China. .
Pokaż więcej
Źródło :
Scientific reports [Sci Rep] 2020 Sep 28; Vol. 10 (1), pp. 15875. Date of Electronic Publication: 2020 Sep 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Genotype*
Anti-Retroviral Agents/*pharmacology
HIV-1/*genetics
Adolescent ; Adult ; Anti-Retroviral Agents/therapeutic use ; CD4 Lymphocyte Count ; Female ; HIV Infections/immunology ; HIV-1/drug effects ; HIV-1/physiology ; Humans ; Male ; Middle Aged ; Young Adult
Czasopismo naukowe
Tytuł :
Evaluation of HIV-specific T-cell responses in HIV-infected older patients with controlled viremia on long-term antiretroviral therapy.
Autorzy :
Behrens NE; Department of Immunobiology, The University of Arizona Health Sciences Center, Tucson, AZ, United States of America.
Wertheimer A; Department of Immunobiology, The University of Arizona Health Sciences Center, Tucson, AZ, United States of America.; Department of Medicine, The University of Arizona Health Sciences Center, Tucson, AZ, United States of America.; College of Medicine, and Bio5 Institute, The University of Arizona Health Sciences Center, Tucson, AZ, United States of America.
Love MB; Department of Immunobiology, The University of Arizona Health Sciences Center, Tucson, AZ, United States of America.
Klotz SA; Department of Medicine, The University of Arizona Health Sciences Center, Tucson, AZ, United States of America.
Ahmad N; Department of Immunobiology, The University of Arizona Health Sciences Center, Tucson, AZ, United States of America.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2020 Sep 17; Vol. 15 (9), pp. e0236320. Date of Electronic Publication: 2020 Sep 17 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Anti-Retroviral Agents/*therapeutic use
HIV Infections/*blood
T-Lymphocytes/*immunology
Viremia/*blood
Adult ; Aged ; Aged, 80 and over ; Anti-Retroviral Agents/administration & dosage ; CD4-CD8 Ratio ; Female ; Granzymes/genetics ; Granzymes/metabolism ; HIV Infections/drug therapy ; HIV Infections/virology ; Humans ; Interferon-gamma/genetics ; Interferon-gamma/metabolism ; Lysosomal-Associated Membrane Protein 1/genetics ; Lysosomal-Associated Membrane Protein 1/metabolism ; Male ; Middle Aged ; Tumor Necrosis Factor-alpha/genetics ; Tumor Necrosis Factor-alpha/metabolism ; Viremia/drug therapy
Czasopismo naukowe
Tytuł :
Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques.
Autorzy :
McBrien JB; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Wong AKH; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
White E; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Carnathan DG; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Lee JH; NantKwest, Culver City, California, USA.
Safrit JT; NantKwest, Culver City, California, USA.
Vanderford TH; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Paiardini M; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA.
Chahroudi A; Department of Pediatrics, Emory University, Atlanta, Georgia, USA.
Silvestri G; Emory Vaccine Center and Yerkes National Primate Research Center, Emory University, Atlanta, Georgia, USA .
Pokaż więcej
Źródło :
Journal of virology [J Virol] 2020 Sep 15; Vol. 94 (19). Date of Electronic Publication: 2020 Sep 15 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Anti-Retroviral Agents/*pharmacology
CD8 Antigens/*immunology
HIV Infections/*immunology
Interleukin-15/*immunology
Simian Acquired Immunodeficiency Syndrome/*immunology
Simian Immunodeficiency Virus/*drug effects
Simian Immunodeficiency Virus/*immunology
Animals ; Anti-Retroviral Agents/therapeutic use ; CD8-Positive T-Lymphocytes/immunology ; Disease Models, Animal ; HIV/drug effects ; Killer Cells, Natural/drug effects ; Lymphocyte Depletion ; Macaca mulatta ; Viral Load ; Viremia/virology ; Virus Latency/drug effects ; Virus Replication/drug effects
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies